Skip to content
FrontierPicks

Dormant

COMP · Compass, Inc.

Conviction · LOW Special situation Catalyst · Housing, homebuilders & proptech

Last analysed ·

Resolved Graded and closed 2026-08-07 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.

Current thesis

Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe.

Kill line

A weekly close below $11 loses the luxury-demand breakout above the June AG-dip shelf and reopens the ~$9.78 June low; a formal NY AG divestiture/CID demand or a Q2 revenue miss versus the $4.0–4.2B guide is the secondary break.

Pick status

Played out resolved published kill line did not fire How this is scored →

Latest analysis and events for COMP —

As of 13 September 2026, the latest FrontierPicks analysis for Compass, Inc. (COMP): Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe.

Kill line: A weekly close below $11 loses the luxury-demand breakout above the June AG-dip shelf and reopens the ~$9.78 June low; a formal NY AG divestiture/CID demand or a Q2 revenue miss versus the $4.0–4.2B guide is the secondary break.

Most recent dated event on file: — catalyst 4d ago.

Current Thesis

Compass's recovery case rests on Anywhere cost savings protecting quarterly earnings despite weaker housing transactions; delivery against Q3 guidance and recovery of the broken $11 shelf would establish whether that case works. This is a conditional reconstruction: the original breakout thesis already failed when the market's 2026-08-28 weekly close of $10.97 breached its published $11 threshold.

The new evidence is adverse. August existing-home sales declined 2.0% month over month to a seasonally adjusted annual rate of 3.98 million, according to the National Association of Realtors (NAR) release dated 2026-09-10. That extends the transaction weakness described in the August dossier. NAR release

As an interpretation of price structure, the narrative is dead in its original breakout form — the 2026-09-11 adjusted close of $10.51 remains below the shelf lost on 2026-08-28 despite the company's 2026-08-04 earnings beat. The narrower recovery hypothesis requires Q3 revenue of at least $3.85 billion, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of at least $275 million, and a weekly close above $11 by the Q3 results publication. A weekly close below $9.78 would invalidate that hypothesis first.

Bullish and bearish views on Compass, Inc.

The model's bull view on Compass, Inc. (COMP), in brief: Savings have measurable operating support. The bear view: National transaction weakness extended again. Both cases follow in full.

Bull Case

  • Savings have measurable operating support. Compass's 2026-08-04 Q2 release reported revenue of $4.306 billion and adjusted EBITDA of $363 million, above its earlier $310–350 million EBITDA guidance. The release raised the 2026 realized synergy goal to $220 million; actioned savings and realized savings remain different measures.
  • Transaction growth survived the acquisition adjustment. The 2026-08-04 release reported Q2 brokerage gross transaction value of $155.2 billion, up 15.9% on a pro forma comparison, and 153,009 transactions, up 7.4% pro forma. These comparisons provide stronger evidence of operating momentum than acquisition-inflated reported growth.
  • Cash generation accompanied reported earnings. Compass reported Q2 operating cash flow of $191 million, free cash flow of $180 million and cash of $694 million on 2026-08-04. Those are historical results; the recovery case fails if Q3 misses the stated revenue or EBITDA floors.

Bear Case

  • National transaction weakness extended again. NAR's 2026-09-10 release put August existing-home sales down 1.2% year over year as well as down sequentially. This is evidence against a broad housing recovery, although national sales alone do not establish Compass's company-specific Q3 outcome. NAR release
  • Management described widespread price reductions. Benzinga's 2026-09-11 report attributed to CEO Robert Reffkin a statement that 42% of listed homes had received price cuts, following his 2026-09-10 CNBC appearance. The article supplies no sampling method or complete measurement window; that percentage cannot establish Compass's transaction growth or realized commission revenue. Benzinga report
  • Higher spending competes with savings. On 2026-08-04, Compass raised its full-year non-GAAP operating-expense guidance to $2.75–2.80 billion, including $35 million associated with a July acquisition. A further increase without a corresponding improvement in realized savings would weaken the earnings-conversion case.

Setup & Price Structure

The supplied adjusted market series records a $10.51 close on 2026-09-11, a three-month price increase of 22.4%, and a price 22.6% below its $13.58 trailing-year high. Its 14-period relative strength index was 34.8. These measurements show that the remaining three-month gain coexists with substantial weakness relative to the high; they do not establish a completed base.

The market's former $11 shelf is now the recovery test. The approximately $9.78 June low documented in the earlier coverage supplies the separate recovery hypothesis's research threshold. This does not revise the original thesis's already-triggered $11 invalidation.

Coverage is observable; ownership crowding is not established. The dated analyst record includes Oppenheimer's $18 target and Wells Fargo's $13 target on 2026-08-05, followed by the September CNBC appearance and Benzinga coverage. This small coverage sample cannot support a claim about expanding participation. Current fund flows, short interest and distance above a rising moving average are missing.

Catalyst Calendar (next 30 days)

  • 2026-10-13 — September existing-home sales. NAR's published schedule places this release at the end of the next-month window. It supplies the next completed-month transaction comparison after August's decline. NAR calendar

The company-specific test remains Q3 results against the guidance issued on 2026-08-04. A confirmed publication date is unavailable in the evidence reviewed.

Elapsed catalysts

  • 2026-09-16 — Federal Reserve decision. The Federal Open Market Committee's official calendar confirms a 2026-09-15–16 meeting. The decision supplies a policy-rate observation; a favorable mortgage-rate response is not assumed. Federal Reserve calendar (passed 4d ago)
  • 2026-09-17 — August pending home sales. NAR's published schedule confirms this release. It tests whether contract signings improved after July's index reading of 71.2, reported on 2026-08-18; another decline would weaken the volume-recovery component. NAR calendar (passed 3d ago)

What Would Change Our Mind

Loss of the June low would end the conditional recovery case: a weekly close below $9.78 is the price invalidation. Q3 revenue below $3.85 billion or adjusted EBITDA below $275 million would independently contradict the operating case, using the lower bounds of Compass's 2026-08-04 guidance.

Positive resolution requires both reported delivery against those floors and a weekly close above the former $11 shelf by the Q3 results publication. Delivery without price recovery would leave the stated recovery case unmet; a price rebound without delivery would leave its earnings explanation unsupported.

Correlation Notes

This is a single-company recovery hypothesis, with housing activity as a proposed economic transmission channel. Compass's 2026-08-04 disclosure of 7.4% pro forma transaction growth and NAR's 2026-09-10 report of declining national sales show why company execution and industry volume require separate measurement. No matched peer-return series is available, so a measured correlation with homebuilders, property technology companies or interest rates cannot be stated.

Notes

  • Headline YoY growth is inflated by the 2026-01-09 Anywhere close - organic momentum reads on pro forma figures (Brokerage GTV +15.9% pro forma vs +98.2% reported in Q2).
  • The New York AG antitrust inquiry opened 2026-06-03 remains open, with no timetable and no publicly disclosed civil investigative demand.
  • CEO-affiliated trusts sell under a Rule 10b5-1 plan adopted 2026-03-03; recurring Form 4 sales are pre-scheduled rather than discretionary.
  • Company stated intent to redeem the $500M 9.75% notes when first callable in Q2 2027 - the interest-expense step-down is a 2027 event.
  • Revenue is volume-driven: existing-home-sales transaction counts and the mortgage path matter more than home-price levels.
  • Compass's antitrust suit against Zillow over listing standards continues; a preliminary injunction was denied in February 2026 and no merits date is public.

Related · shared themes